Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

Michael Benatar(University of Miami), G. Garcia Gutierrez, Yindi Li(University of Iowa), Volkan Granit(Biohaven Pharmaceuticals (United States)), Lyle W. Ostrow(Johns Hopkins University), Lily Wang(Taichung Veterans General Hospital), Stephan Züchner(University of Miami), Patrice L. Whitehead, Ted M. Burns(University of Virginia), Constantine Farmakidis, Julie Steele(University of South Florida), Jaya Trivedi(The University of Texas at San Antonio Health Science Center), Sumaira Hussain, Natalia Ravelo, Marielle Wallace, Rosa Rademakers(Indiana University – Purdue University Indianapolis), Jacob L. McCauley(University of Cambridge), Mazen M. Dimachkie(University of Kansas Medical Center), Mamatha Pasnoor, James B. Caress(The University of Texas at San Antonio Health Science Center), Melanie Glenn, Omar Jawdat, Wendy Levy, Anne Cooley(Rancho BioSciences (United States)), Andrea Malaspina(University College London), Jeffrey Statland(The University of Texas at San Antonio Health Science Center), Erik P. Pioro(University of British Columbia), Jéssica Medina, Tina Liu, Carlayne E. Jackson(The University of Texas at San Antonio Health Science Center), Andrea Swenson(The University of Texas at San Antonio Health Science Center), John Ravits(University of California San Diego), Melissa Currence, Jeri Sieren, Hellen Tanui, Ayla McCally, Yolanda Harness, Jessica Hernandez, Maria Elena Paredes, Emilee Gibson, Andrew Heim, Joanne Wuu(The University of Texas at San Antonio Health Science Center), Ashley Manso, Laura Herbelin, Richard J. Barohn(University of Missouri Health System), Jonathan Katz(The University of Texas at San Antonio Health Science Center), Sherri Anderson, Duaa Jabari, Michaela Walker, Lanyu Zhang(The University of Texas at San Antonio Health Science Center)
Neurology
May 8, 2020
Cited by 201


Related Papers